Sigma Planning Corp’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-92,500
| Closed | -$2.23M | – | 1379 |
|
|
2023
Q1 | $2.23M | Sell |
92,500
-61,290
| -40% | -$1.48M | 0.07% | 273 |
|
|
2022
Q4 | $1.63M | Buy |
153,790
+100
| +0.1% | +$1.06K | 0.06% | 334 |
|
|
2022
Q3 | $692K | Hold |
153,690
| – | – | 0.03% | 597 |
|
|
2022
Q2 | $615K | Buy |
153,690
+28,070
| +22% | +$112K | 0.02% | 670 |
|
|
2022
Q1 | $920K | Buy |
125,620
+3,625
| +3% | +$26.5K | 0.03% | 569 |
|
|
2021
Q4 | $686K | Buy |
121,995
+1,650
| +1% | +$9.28K | 0.02% | 693 |
|
|
2021
Q3 | $770K | Buy |
120,345
+9,880
| +9% | +$63.2K | 0.02% | 632 |
|
|
2021
Q2 | $931K | Buy |
110,465
+25,130
| +29% | +$212K | 0.03% | 575 |
|
|
2021
Q1 | $896K | Buy |
85,335
+26,245
| +44% | +$276K | 0.03% | 541 |
|
|
2020
Q4 | $1M | Buy |
59,090
+450
| +0.8% | +$7.62K | 0.03% | 429 |
|
|
2020
Q3 | $752K | Sell |
58,640
-400
| -0.7% | -$5.13K | 0.03% | 473 |
|
|
2020
Q2 | $833K | Sell |
59,040
-17,840
| -23% | -$252K | 0.04% | 435 |
|
|
2020
Q1 | $707K | Sell |
76,880
-3,505
| -4% | -$32.2K | 0.04% | 396 |
|
|
2019
Q4 | $1.2M | Buy |
80,385
+11,485
| +17% | +$171K | 0.05% | 355 |
|
|
2019
Q3 | $470K | Buy |
68,900
+10,950
| +19% | +$74.7K | 0.02% | 592 |
|
|
2019
Q2 | $701K | Buy |
+57,950
| New | +$701K | 0.04% | 448 |
|